Membrane sweeping versus dinoprostone vaginal insert in the management of pregnancies beyond 41 weeks with an unfavorable cervix

Journal of Perinatology

Volumn 19, Issue 2, 1999, Pages 88-91

  Magann, Everett F ^b,d   Chauhan, Suneet P ^c   McNamara, Michael F ^a   Bass, J David ^b   Estes, Colleen M ^a   Morrison, John C ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIC AGENT; PROSTAGLANDIN E2;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPPOSITORY; UTERINE CERVIX RIPENING;

ADULT; CERVICAL RIPENING; DINOPROSTONE; FEMALE; HUMANS; OXYTOCICS; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SUPPOSITORIES;

EID: 0033084779     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200133     Document Type: Article

References (16)

1. Rayburn WF, Morley ME, Stempel LE. Antepartum prediction of the postmature infant. Obstet Gynecol 1982;60:148-53.
2. Lagrew DC, Freeman RK. Management of postdate pregnancy. Am J Obstet Gynecol 1986;154:8-13.
3. Yeh SY, Read JA. Management of postterm pregnancy in a large obstetric population. Obstet Gynecol 1982;60:282-7.
4. Magann EF, Chauhan SP, Nevils BG, McNamara MF, Kinsella J, Morrison JC. Management of pregnancies beyond 41 weeks' gestation with an unfavorable cervix. Am J Obstet Gynecol 1998;178:1279-87.
5. Keirse MJN, Phil D. Prostaglandins in preinduction cervical ripening: metaanalysis of worldwide clinical experience. J Reprod Med 1993;38:89-100.
6. Witter FR, Mercer BM. Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. J Matern Fetal Med 1996;5:64-9.
7. Chyu JK, Strassner HT. Prostaglandin E2 for cervical ripening: a randomized comparison of Cervidil versus Prepidil. Am J Obstet Gynecol 1997;177:606-11.
8. McColgin SW, Hampton HL, McCaul JF, Howard PR, Andrew ME. Stripping of membranes at term: can it safely reduce the incidence of postterm pregnancies? Obstet Gynecol 1990;76:678-80.
9. Berghella V, Rogers RA, Lescale K. Stripping of membranes as a safe method to reduce prolonged pregnancies. Obstet Gynecol 1996;87:927-31.
10. Gupta R, Vasishta K, Sawhney H, Ray P. Safety and efficacy of stripping of membranes at term. Int J Obstet Gynecol 1998;60:115-20.
11. Bochner CJ, Williams J, Castro L, Medearis A, Hoblel CJ, Wade M. The efficacy of starting post-term antenatal testing at 41 weeks as compared with 42 weeks' of gestation. Am J Obstet Gynecol 1988;159:550-4.
12. Guidetti DA, Divon MY, Langer O. Postdate fetal surveillance: is 41 weeks too early? Am J Obstet Gynecol 1989;161:91-3.
13. Usher RH, Boyd ME, McLean FH, Kramer MS. Assessment of fetal risk in postdate pregnancies. Am J Obstet Gynecol 1988;158:259-64.
14. 2 gel and membrane stripping. J Matern Fetal Med 1997;6:71-8.
15. Naeye RL. Causes of perinatal mortality excess in prolonged gestations. Am J Epidemiol 1978;108:429-34.
16. Crane J, Bennett K, Young D, Windrim R, Kravitz H. The effectiveness of sweeping membranes at term: a randomized trial. Obstet Gynecol 1997;89:586-90.